Also, other NSAIDs like sulindac have proven to induce apoptosis in colon cancer cells, thereby pointing to a class effect of COX inhibitors in CRC treatment or prevention that may be attributable to the ability of these drugs to inhibit COX-2 function [188, 195]. This evidence concerns the gene PTGS2 and colorectal carcinoma.